Have a feature idea you'd love to see implemented?
Let us know!
ACET Adicet Bio Inc
Price (delayed)
$1.44
Market cap
$118.66M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.52
Enterprise value
-$86.28M
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of 'off-the-shelf' gamma delta
Highlights
Adicet Bio's debt has decreased by 16% YoY and by 4.5% QoQ
ACET's EPS is up by 14% since the previous quarter and by 7% year-on-year
The quick ratio has increased by 15% YoY but it has decreased by 12% from the previous quarter
The company's net income fell by 19% YoY
Adicet Bio's equity has decreased by 9% QoQ
Key stats
What are the main financial stats of ACET
Market
Valuations
Earnings
Shares outstanding
82.4M
Market cap
$118.66M
Enterprise value
-$86.28M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.5
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$137.29M
EBITDA
-$127.62M
Free cash flow
-$92.58M
Per share
Balance sheet
Liquidity
EPS
-$2.52
Free cash flow per share
-$1.02
Book value per share
$2.86
Revenue per share
$0
TBVPS
$2.97
Total assets
$268.84M
Total liabilities
$33.73M
Debt
$19.13M
Equity
$235.11M
Working capital
$210.45M
Debt to equity
0.08
Current ratio
12.75
Quick ratio
12.52
Net debt/EBITDA
1.61
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-54.8%
Return on equity
-63.9%
Return on invested capital
-281.1%
Return on capital employed
-54.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ACET stock price
How has the Adicet Bio stock price performed over time
Intraday
-5.26%
1 week
-3.36%
1 month
0.7%
1 year
4.35%
YTD
-23.81%
QTD
0%
Financial performance
How have Adicet Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$147.55M
Net income
-$137.29M
Gross margin
N/A
Net margin
N/A
ACET's operating income is down by 20% YoY
The company's net income fell by 19% YoY
Growth
What is Adicet Bio's growth rate over time
Valuation
What is Adicet Bio stock price valuation
P/E
N/A
P/B
0.5
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ACET's EPS is up by 14% since the previous quarter and by 7% year-on-year
ACET's price to book (P/B) is 56% lower than its 5-year quarterly average of 1.2 but 6% higher than its last 4 quarters average of 0.5
Adicet Bio's equity has decreased by 9% QoQ
Efficiency
How efficient is Adicet Bio business performance
ACET's ROE has shrunk by 55% YoY
Adicet Bio's return on assets has shrunk by 51% YoY
Adicet Bio's ROIC has decreased by 39% YoY and by 3.5% from the previous quarter
Dividends
What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ACET.
Financial health
How did Adicet Bio financials performed over time
ACET's current ratio is up by 15% year-on-year but it is down by 11% since the previous quarter
The quick ratio has increased by 15% YoY but it has decreased by 12% from the previous quarter
Adicet Bio's debt is 92% lower than its equity
Adicet Bio's debt has decreased by 16% YoY and by 4.5% QoQ
ACET's debt to equity is down by 11% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.